1
Total Mentions
1
Documents
0
Connected Entities
Organization referenced in documents
EFTA00506070
ves 5 EFTA00506074 2013-08-22 Strong in vitro & preclinical data provide consistent rationale why EPB-348 is more potent than other antivirals Active Drug VZV EP8-348 • thkintsciclovii Stn. iptoditvg) wal l. 1j1 Thyrnitine 142G Kings.O Welts • YAsDNA Polymerise H2G has improved cellular pe
No connected entities